Spectrophon

Company Overview

Snapshot

Founded in January 2012 by Gleb Zilberstein and Uriel Halavee, Spectrophon operates with 11–50 employees. The company has secured funding across one disclosed round. A significant development for Spectrophon was a new study by NASA in January 2025, focusing on its technology.

Business overview

Spectrophon develops health and sport sensors integrated with software for wearable devices and smartphones. The company's technology focuses on applications such as glucometry, calorimetry, body dehydration monitoring, and lactate monitoring. It serves the health tech and life sciences sector, specifically within digital healthcare and patient remote monitoring, utilizing patented chemochromic layers and algorithms for signal processing.

Strategic signal

In January 2025, NASA conducted a new study on Spectrophon's technology, indicating significant external validation and potential for broader applications beyond its current health and sport sensor focus. This signals to investors a strong scientific endorsement and potential for market expansion into areas requiring advanced sensor capabilities, reinforcing the company's innovative approach to smart sensor technology.

Company Intelligence Q&A

What is Spectrophon's core technology?

Spectrophon's core technology involves patented chemochromic layers made from sensitive materials applied to photoelectronic components, combined with patented algorithms for processing sensor signals. This allows for integration into wearable devices and smartphones.

What are the primary applications of Spectrophon's technology?

Spectrophon's technology is primarily applied to glucometry, calorimetry (calories burned monitoring), body dehydration monitoring, and lactate monitoring, integrated into devices like smartwatches and smartphones.

Has Spectrophon's technology undergone clinical testing?

Yes, Spectrophon's technology has been successfully tested in clinical studies for glucometry and dehydration monitoring, as well as focus studies for calorimeter and lactate monitoring.

What significant external validation did Spectrophon receive recently?

In January 2025, NASA conducted a new study on Spectrophon's technology, highlighting its potential and capabilities.

Which markets does Spectrophon target?

Spectrophon targets global markets including Asia, Europe, and the United States, focusing on areas like digital healthcare and patient remote monitoring.